DEC 22
New Users Please Click to Register
Renew or Upgrade your Existing  Account

Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
cme CE free (CME/CE requires payment)
ISHD Hemodialysis University Chicago (2012-2014)
ISHD Hemodialysis University Shanghai 2013



Brigham Nephrology Board Review Course.   
Flash or IPAD slide/audio
Boston, MA; August, 2013

Hematuria - Board Review
Martina M. McGrath, MD

Pregnancy and Renal Disease
Ravi Thadhani, MD






Advances in CKD 2014 (PART 8)   
Flash or IPAD slide/audio
Las Vegas, NV; January 2014


Peritoneal Dialysis for Children with AKI in Nigeria: Saving Young Lives with Improvisations
Christopher Esezobor, MD

CKD Predictions and Concepts of progressors and non-progressors
Macaulay Onuigbo, MD

Circulating Fibroblast Growth Factor-2 (FGF-2) induces proteinuria and glomerular injury in young mice
Charu Gupta, MD

Keynote Address: A Different Approach to the Dialysis Prescription
John Daugirdas, MD


Hypertension, Cardiovascular
Orthostatic hypotension in the elderly; normal values
Targeting nocturnal hypertension
Treatment-resistant hypertension and CV risk
If I had resistant hypertension
Dalteparin for prevention of venous thromboembolism
Left atrial appendage closure for a. fib.
Salt substitutes help control BP
Low-dose aspirin for pre-eclampsia
AHA guidelines for management of a. fib.
Atomoxetine better than midodrine for orthostatic hypotension

CKD, Dialysis
Calories don't matter re infection in the ICU
Gene variants for vitamin D and BP
Warfarin ups bleeding risk in CKD
Cholecalciferol repletion in HD patients
PD outcomes differ in US vs. Korea
Early predictors of ESRD
Allopurinol vs. febuxostat
Sickle cell trait ups CKD risk
Frozen feces cure Clostridia infection
PEG3350 for hepatic encephalopathy
Postimplantation Xray predicts PD catheter success
Temporary HD catheters: new findings
Warfarin ups risk of aortic stiffening
Pill burden bad for phos binder efficacy
Fiber intake related to all-cause mortality
Percent fall in eGFR as a surrogate endpoint Angiotensin blockade and CKD progression
Intensive low salt diet education improves CKD
Inpatient hemodialysis without anticoagulation
Economics of rt-PA dialysis catheter prophylaxis
How PTH relates to FGF23 transcription
Sodium and potassium excretion and renal outcomes
Elderly may not require as high a blood Hb level
Dabigatran-induced glomerular hemorrhage
Thyroid function tests in ESRD
High output heart failure with AV fistulas

Clinical Nephrology
Dx and tx of hyponatremia (review)
Rituximab for minimal change disease in adults
Misdiagnosing amyloidosis as minimal change
Caffeine intake lowers kidney stone risk
Hourly oral sodium chloride to treat hyponatremia
Fenoldopam use in AKI: RCT
Perioperative aspirin and clonidine no good
Zirconium cyclosilicate for hyperkalemia
ROKS nomogram to predict stone risk
Should chloride-rich crystalloids still be used?
Patiromer to prevent hyperkalemia
BP and angiotensin blockade in adult PKD
New marker of idiopathic membranous nephropathy
Desmopressin, hypopnatremia, and brain damage

This update's selected ASN 2014 abstracts

Dietary sodium and urinary metabolome; Meat eating ups HTN risk; PRA associates with CV risk; Apheresis to remove soluble Flt1 in preeclampsia; Reduced uric acid excretion a marker for high endogenous ouabain; Low energy shockwaves to treat renovascular disease in pigs; Contralateral GFR after kidney revascularization; Novel gene for HTN in Hispanics.

Ultrasound to guide AV fistula maturation; Criteria to diagnose catheter-related bloodstream infection; Estimating Kru by serum filtration markers; UF rate risk in HD depends on body size and gender; Remote ischemic preconditioning in HD; More on dialysis dose from the VA-NIH trial; Death risk in daily home hemo vs. PD; Specialized care program lower hosp. admissions; Use of niacin marks slower CKD progression; APOL1 variants and progression; Sickle cell trait and risk of progression; Iron dose and infection risk; PTH, vitamin D, and heart failure risk in MESA; Cholecalciferol supplementation in HD; Proteinuria alters tubular handling of phosphate; Kidney regulation of blood FGF23; FGF receptor blockade attenuates LVH (in rats); FGF23 and frailty in the elderly; Influenza vaccine lowers pneumococcal pneumonia risk; Timing of arrhythmias during the dialysis schedule; Low predialysis sodium magnifies benefits of daily HD on LV mass; Atrial fib and bradycardia in dialysis patients; Implantable cardioverter defibrillators in dialysis patients; High TSH and mortality in ESRD.

Clinical Nephrology
Percent creatinine excretion by renal tubules vs. GFR; Estimating GFR from multiple blood biomarkers; Change in eGFR as good as change in measured GFR in CRIC; Remote ischemic preconditioning good for kidney and heart in kids undergoing cardiac surgery; Furosemide stress test to predict outcome of AKI; Autologous stem cell transplantation in primary AL amyloidosis; Mycophenolate in C3 GN; Histologic vs. clinical remission in lupus GN; Repeat renal biopsy utility in lupus GN; Maintenance therapy with cyclophosphamide vs. mycophenoloate in less severe lupus GN; Rituxilup regimen for lupus - long term follow up; Relapse in ANCA vasculitis and serum calprotectin; Extended cyclophosphamide good for ANCA associated vasculitis.

Transplant: Tacrolimus levels in AA patients; Creatinine clearance vs iothalamate to measure kidney function in prospective donors; Survival in kidney donors with pre-existing HTN; Gout risk increased in living kidney donors.
 (Kidney Week 2014...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: January 26, 2015 (Jan26)
Jan26 Hemodialysis abstracts from the upcoming Annual Dialysis Conference in New Orleans
Jan24 FDA committee recommends approval of drug to treat invasive aspergillosis.
Jan09 New variant of aminoglycosides does not impair hearing.
Jan09 Monthly dose of PCSK9 inhibitor lowers serum cholesterol
Dec19 Ibuprofen extends lifespan in yeast., worms, and fruit flies.
Nov18 Ultrasonography for nephrologists course Jan 10-11, 2015
Nov17 JAMA: New hyperkalemia sorbent effective in reducing hyperkalemia
Nov08 Fiber supplementation lower p-cresol levels
Nov06 Google genomics: storing thousands of genomes in the cloud
Nov04 New portable ultrasound device is disruptive technology.
Oct23 ASN FAQ re Ebola and dialysis
Oct23 CDC guidlines for dialyzing patients with Ebola virus infection
Oct12 Harvard scientists produce insulin-producing pancreatic beta cells on a large scale.
Oct09 Off topic: Levi, Foschi, Hoeistad, and Essen: Abundant heat production...
Oct09 Off topic: One million times the energy density of gasoline.
Oct08 Off topic: The world has just changed, but you don't know it yet.
Sep01 New study confirms benefits of a low carb diet, even when eating some saturated fat.
Sep01 PCSK9 inhibitor arilocumab lowers cholesterol and cardiovascular events
Aug30 Novel heart failure drug shows great promise.
Aug03 Cyanotoxin factsheet from the EPA.
General Advances Emphasis
Thyroid function tests in end stage renal disease.
Drs. Kulkarni and Holley describe the emerging evidence that thyroid dysfunction should be sought and perhaps treated in dialysis patients; in the Nov/Dec issue of Seminars in Dialysis, which has articles about the usefulness of many other laboratory tests in ESKD as well.. (more...)

Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation
Dr. Dousdampanis and colleagues review the latest evidence regarding low magnesium and CKD, and whether we should treat it; in the October issue of Hemodial Int (more...)

Sailing between Scylla and Charybdis: The high serum K - low dialysate K quandary
Should we use a 3 K bath for most patients? Are 1K and zero K bath's a no-no? Drs. Labriola and Jadoul review the evidence in the Sept/Oct issue of Seminars in Dialysis. (more...)

A stepwise approach for the management of poisoning with extracorporeal treatments Few are using hemoperfusion anymore, and poisoning requires an integrated approach. Dr. Ghannoum and colleagues provide a nice overview in the July/Aug issue of Seminars in Dialysis. (more...)

Hemodialysis for infants, children, and adolescents
Drs. Kaur and Davenport review techniques for performing hemodialysis in children; in the July issue issue of Hemodial Int (more...)

Urgent-start peritoneal dialysis: what are the problems and their solutions? Dr. Mahnensmith discusses this new approach to AKI or acute-on-chronic kidney failure, its advantages and potential problems; in the May/June issue of Seminars in Dialysis. (more...)

Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome
Dr. Sands and colleagues delve into large databases to better understand the occurrence and risk factors for intradialytic hypotension; in the April issue of Hemodial Int (more...)

Hemodialysis-associated cardiomyopathy: a newly defined disease entity Drs. McIntyre and Odudu describe their latest results regarding myocardial stunning; in the Mar/Apr issue of Seminars in Dialysis. (more...)

Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants Dr. Clarke and colleagues review why adherence is so important to outcomes, and methods that have been suggested to improve this problem; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Approach to prophylactic measures for central venous catheter- related infections in hemodialysis: A critical review
Dr. Silva and colleagues go over what we know works, and which treatments are still experimental; in the Jan-Feb issue of Hemodial Int (more...)

Infrequent dialysis: a new paradigm for hemodialysis initiation Dr. Rhee and colleagues present a novel idea; starting out with twice-a-week dialysis in incident patients with substantial residual kidney function, and discuss potential benefits vs. risks. in the Nov/Dec issue of Seminars in Dialysis. (more...)

Is it time for "green" dialysis?
Dr. Agar talks about power, water, and waste disposal; in the October issue of Hemodial Int (more...)

Improving outcomes in patients with lupus and end-stage renal disease Inda-Filho and colleagues talk about neglected areas in the management of ESRD patients with lupus nephritis; in the Sep/Oct issue of Seminars in Dialysis. (more...)

Essential components of an infection prevention program for outpatient hemodialysis centers Hess and Bren write about how to set this up, potential pitfalls, and expected benefits; in the July/Aug issue of Seminars in Dialysis. (more...)

Mycophenolate fetal toxicity and risk evaluation and mitigation strategies, including complying with FDA requirements.
Kim, Rostas, and Gabardi discuss the potential problems of using mycophenolate mofetil in pregnancy; in the June issue of Am J Transplantation (more...)

What nephrologists need to know about vascular access cannulation Dinwiddie, Brouwer, and colleagues give valuable tips regarding cannulation of vascular access; in the May/June issue of Seminars in Dialysis. (more...)

Physical examination: How to examine the arm with arteriovenous fistula
Sousa and colleagues review the various methods and pitfalls; in the April issue of Hemodial Int (more...)

Diagnosis and treatment of peripheral arterial disease in CKD patients Yevzlin and Gimelli describe practical algorithms for managing peripheral arterial disease in CKD patients; in the March/April issue of Seminars in Dialysis. (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

  Advances in CKD (Renal Research Institute) (2014) (2013) (2012) (2011) (2010) (2009)
  Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
  The Brigham Renal Board Review Course: Selected Lectures (2013) -- (2012) -- (2011)
  American Society of Hypertension (2013)   (2012)   (2011)
  Renal Physicians Association (2012) (2011) (2010) (2009)
  American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
  Fistula First (2010)
  Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
  National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
  American Society for Nephrology Renal Week (2009) (2008) (2007)
  American Society for Nephrology Board Review Course (2008) (2007)
  American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99